Your browser doesn't support javascript.
loading
NGS-based profiling of key cancer genes in Indian triple-negative breast cancer patients reinforces molecular heterogeneity of the disease.
Sahasrabuddhe, Nandini A; Korlimarla, Aruna; Kulkarni, Madhura; Kusuma, Vinay; Prabhu, Jyothi S; Dixit, Santosh; Deshmukh, Chetan; Sridhar, T S; Phatak, Aditya; Koppiker, Chaitanyananda.
Affiliation
  • Sahasrabuddhe NA; PierianDx India Pvt. Ltd. Pune, Maharashtra, India.
  • Korlimarla A; St. John's Research Institute, Bengaluru, Karnataka, India.
  • Kulkarni M; Prashanti Cancer Care Mission (PCCM); Center for Translational Cancer Research - a joint initiative of PCCM and Indian Institute of Science Education and Research (IISER), Pune, Maharashtra, India.
  • Kusuma V; PierianDx India Pvt. Ltd. Pune, Maharashtra, India.
  • Prabhu JS; St. John's Research Institute, Bengaluru, Karnataka, India.
  • Dixit S; Prashanti Cancer Care Mission (PCCM); Center for Translational Cancer Research - a joint initiative of PCCM and Indian Institute of Science Education and Research (IISER), Pune, Maharashtra, India.
  • Deshmukh C; Prashanti Cancer Care Mission (PCCM), Pune, Maharashtra, India.
  • Sridhar TS; St. John's Research Institute, Bengaluru, Karnataka, India.
  • Phatak A; PierianDx India Pvt. Ltd. Pune, Maharashtra, India.
  • Koppiker C; Prashanti Cancer Care Mission (PCCM); Center for Translational Cancer Research - a joint initiative of PCCM and Indian Institute of Science Education and Research (IISER), Pune, Maharashtra, India.
Indian J Cancer ; 58(4): 598-602, 2021.
Article in En | MEDLINE | ID: mdl-34975100
ABSTRACT
Triple-negative breast cancers (TNBC) are one of the most aggressive forms of breast cancers. With poor patient outcomes, it presents a great burden on the healthcare systems. There have been some efforts to explore the genomic changes that occur in TNBCs. However, there is not enough data on Indian TNBCs. We sought to understand the mutational landscape of key cancer-associated genes in Indian TNBC patients using TruSeq Cancer Amplicon Panel. We sequenced 51 TNBC patient samples and found great heterogeneity amongst samples with respect to the genomic variants. Several previously reported including alterations in PI3K-AKT pathway genes were also identified. Likewise, we identified several novel high-frequency variants, for example, GNAQ F341S (17%), the functional role of which remains unclear. Our study lays the foundation of larger efforts needed to understand the genomic landscape of Indian TNBCs which can aid in classification and better therapeutic management of patients.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Heterogeneity / Genomics / High-Throughput Nucleotide Sequencing / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Indian J Cancer Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Heterogeneity / Genomics / High-Throughput Nucleotide Sequencing / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Indian J Cancer Year: 2021 Document type: Article Affiliation country: